Skip to main content
Figure 1 | BMC Immunology

Figure 1

From: Alteration of DSS-mediated immune cell redistribution in murine colitis by oral colostral immunoglobulin

Figure 1

Influence of therapeutically applied colostral compounds on clinical severity of DSS-induced colitis. The indicated therapeutics (bLf, sIgA, IgG, and BC) and controls (NaCl and BSA) were applied parallel to DSS treatment. Weight loss was either represented during the induction phase of colitis as percentage of body weight from day 1 (A) or during the recovery phase as percentage from day 8 (B). Clinical disease activity was determined by scoring changes in body weight, occult blood (C) and stool consistency (D) as shown in Additional file 3. Values are means ± SD of n = 8 (NaCl), n = 6 (BC, sIgA, IgG), and n = 5 (bLf, BSA) mice.

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us